Dissemin is shutting down on January 1st, 2025

Published in

Protocols

DOI: 10.1002/14651858.cd008576

Cochrane Collaboration, Cochrane Database of Systematic Reviews

DOI: 10.1002/14651858.cd008576.pub2

Cochrane Collaboration, Cochrane Database of Systematic Reviews

DOI: 10.1002/14651858.cd008576.pub3

Links

Tools

Export citation

Search in Google Scholar

Metroplasty versus expectant management for women with recurrent miscarriage and a septate uterus

Journal article published in 2010 by C. R. Kowalik, Kowalik Cr, M. Goddijn ORCID, Emanuel Mh, M. H. Emanuel, M. Y. Bongers, Bongers My, T. Spinder, Spinder T. De, J. H. de Kruif, Kruif Jh, Mol Bwj, Ben Willem J. Mol, Maas Jan Heineman, Heineman Mj
This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Red circle
Preprint: archiving forbidden
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

No randomised controlled studies have been identified which assess the effectiveness of operative resection of a septate uterus (a septate uterus is a division of the womb into two cavities, instead of one cavity) in women with recurrent miscarriage (RM). Recurrent miscarriage is seen more often in women with a septate uterus in comparison with women with a normal uterus. Surgical removal (hysteroscopic metroplasty) of this septum can potentially improve pregnancy outcomes in women with RM. However, judgment as to whether this treatment is effective is not possible due to a lack of available randomised evidence.